KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients., PMID:40372495
KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients., PMID:40372495
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization., PMID:40295001
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization., PMID:40295001
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis., PMID:40214505
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis., PMID:40214505
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment., PMID:40182035
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment., PMID:40182035
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform., PMID:39799133
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform., PMID:39799133
Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development., PMID:39687626
Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development., PMID:39687626
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer., PMID:39658611
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer., PMID:39658611
Single Cell Droplet-Based Efficacy and Transcriptomic Analysis of a Novel Anti-KLRG1 Antibody for Elimination of Autoreactive T Cells., PMID:39281869
Single Cell Droplet-Based Efficacy and Transcriptomic Analysis of a Novel Anti-KLRG1 Antibody for Elimination of Autoreactive T Cells., PMID:39281869
Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development., PMID:39211194
Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development., PMID:39211194
Temporal Alterations in CD8+ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes., PMID:38967999
Temporal Alterations in CD8+ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes., PMID:38967999
Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform., PMID:38798447
Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform., PMID:38798447
FcαRI (CD89) is upregulated on subsets of mucosal and circulating NK cells and regulates IgA-class specific signaling and functions., PMID:38677592
FcαRI (CD89) is upregulated on subsets of mucosal and circulating NK cells and regulates IgA-class specific signaling and functions., PMID:38677592
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles., PMID:38650930
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles., PMID:38650930
KLRG1, Another Opportunity for a Breakthrough in MTCL., PMID:38568191
KLRG1, Another Opportunity for a Breakthrough in MTCL., PMID:38568191
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity., PMID:38296598
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity., PMID:38296598
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes., PMID:38252421
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes., PMID:38252421
Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia., PMID:38094307
Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia., PMID:38094307
KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir., PMID:37741278
KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir., PMID:37741278
Transplantation elicits a clonally diverse CD8+ T cell response that is comprised of potent CD43+ effectors., PMID:37590141
Transplantation elicits a clonally diverse CD8+ T cell response that is comprised of potent CD43+ effectors., PMID:37590141
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response., PMID:37539479
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response., PMID:37539479
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes., PMID:37432736
Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes., PMID:37432736
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts., PMID:37392736
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts., PMID:37392736
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood., PMID:36818683
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood., PMID:36818683
Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like Autoimmunity., PMID:36637239
Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-like Autoimmunity., PMID:36637239
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects., PMID:36505477
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects., PMID:36505477
Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation., PMID:36505452
Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation., PMID:36505452
Biomarkers of AIT: Models of prediction of efficacy., PMID:36457722
Biomarkers of AIT: Models of prediction of efficacy., PMID:36457722
KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry., PMID:36306514
KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry., PMID:36306514
Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms., PMID:36054934
Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms., PMID:36054934
Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis., PMID:35711452
Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis., PMID:35711452
Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells., PMID:35618289
Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells., PMID:35618289
Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan., PMID:35572546
Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan., PMID:35572546
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation., PMID:35527320
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation., PMID:35527320
Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells., PMID:35131904
Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells., PMID:35131904
Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry., PMID:35008688
Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry., PMID:35008688
Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients., PMID:34186161
Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients., PMID:34186161
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer., PMID:34083422
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer., PMID:34083422
Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors., PMID:34016721
Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors., PMID:34016721
Development of Antihuman Killer Cell Lectin-Like Receptor Subfamily G Member 1 Monoclonal Antibodies for Flow Cytometry., PMID:33900816
Development of Antihuman Killer Cell Lectin-Like Receptor Subfamily G Member 1 Monoclonal Antibodies for Flow Cytometry., PMID:33900816
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus., PMID:33791695
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus., PMID:33791695
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer., PMID:33757987
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer., PMID:33757987
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals., PMID:33658358
Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects., PMID:33351781
Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects., PMID:33351781
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics., PMID:32954948
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics., PMID:32954948
Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity., PMID:32905903
Cancer cells educate natural killer cells to a metastasis-promoting cell state., PMID:32645139
Cancer cells educate natural killer cells to a metastasis-promoting cell state., PMID:32645139
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice., PMID:32275969
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice., PMID:32275969
HBV vaccination and HBV infection induces HBV-specific natural killer cell memory., PMID:32229546
HBV vaccination and HBV infection induces HBV-specific natural killer cell memory., PMID:32229546
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions., PMID:31823769
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions., PMID:31823769
Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1+CD8 T cells., PMID:31664180
Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1+CD8 T cells., PMID:31664180
For research use only. Not for human or drug use.
